Disease Course and Treatment Responses in Children With RelapsingMyelin Oligodendrocyte Glycoprotein Antibody-Associated Disease

Creative Commons License

Hacohen Y., YiWong Y., Lechner C., Jurynczyk M., Wright S., KONUŞKAN B., ...Daha Fazla

JAMA NEUROLOGY, cilt.75, sa.4, ss.478-487, 2018 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 75 Sayı: 4
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1001/jamaneurol.2017.4601
  • Dergi Adı: JAMA NEUROLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.478-487
  • Hacettepe Üniversitesi Adresli: Evet

Özet

IMPORTANCE Myelin oligodendrocyte glycoprotein antibodies (MOG-Abs) are consistently identified in a range of demyelinating disorders in adults and children. Current therapeutic strategies are largely center specific, and no treatments have been formally evaluated.